Abstract
Purpose
The management of chronic ocular hypotony and complicated proliferative vitreoretinopathy-related retinal detachment represents a challenge. Being non-absorbable and non-biodegradable, a silicone oil implant is expected to restore the volume and the intraocular pressure of the globe, as well as to approximate the detached retina. Further advantages could be a long-term tamponade potential, absence of toxicity, and prevention of silicone oil emulsification or anterior chamber oil-prolapse. The aim of this study was to assess the histological tolerance of the silicone oil implant in a pig model.
Methods
A seamless silicone balloon implant with optional surface modifications was developed. Mini pigs were used as experimental animals, and three variants of silicone implants with different surfaces were tested: uncoated, NCO-sP(EO-stat-PO) coated, and heparin-NCO-sP(EO-stat-PO) coated silicone implants. An extracapsular lens extraction was achieved via a standard phacoemulsification followed by a standard three-port vitrectomy. The implant was then placed in the posterior segment and filled with 5000 centistoke silicone oil. One month later, the pigs were euthanized, the eyes were enucleated, and histological specimens were prepared for microscopy.
Results
The analysis of the histology revealed that adverse histological changes in conjunctiva, cornea, iris, and ciliary body could be excluded in all eyes operated on regardless of which variant of implant had been employed. The retina as the implant-contacting ocular tissue showed overall good tolerance, although some inflammatory reaction and fibrous proliferation was evident in some cases.
Conclusions
The silicone oil implant is a promising candidate and has the potential to fulfill clinical requirements to act as a long-term intraocular tamponade agent. The heparin-NCO-sP(EO-stat-PO) coating approach could lead to a novel bioactive surface for intraocular devices with excellent properties to hinder cell adhesion and protein adsorption, although further studies will be necessary to evaluate long-term biocompatibility and long-term resistance to biological attacks.
Similar content being viewed by others
References
Jonas JB, Vossmerbaeumer U, Kamppeter BA (2004) Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 82(5):637
Arevalo JF, Garcia RA, Fernandez CF (2004) Anterior segment inflammation and hypotony after posterior segment surgery. Ophthalmol Clin N Am 17(4):527–537
De Smet MD, Gunning F, Feenstra R (2005) The surgical management of chronic hypotony due to uveitis. Eye (Lond) 19(1):60–64
Tosi GM, Schiff W, Barile G, Yoshida N, Chang S (2005) Management of severe hypotony with intravitreal injection of viseoeplastic. Am J Ophthalmol 140(5):952–954
Küçükerdönmez C, Beutel J, Bartz-Schmidt KU, Gelisken F (2009) Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate. Br J Ophthalmol 93(2):235–239. doi:10.1136/bjo.2008.143834.
Kapur R, Birnbaum AD, Goldstein DA, Tessler HH, Shapiro MJ, Ulanski LJ, Blair MP (2010) Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Retina 30(1):140–145. doi:10.1097/IAE.0b013e3181b32f06
Cadera W, Harding PW, Gonder JR, Hooper PL (1993) Management of severe hypotony with intravitreal injection of Healon. Can J Ophthalmol 28(5):236–237
Giuffrè I, Taverniti L, Di Staso S (2004) The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma. Eur J Ophthalmol 14(6):508–513
Schramm C, Spitzer M, Henke-Fahle S, Steinmetz G, Januschowski K, Heiduschka P, Geis-Gerstorfer J, Biedermann T, Bartz-Schmidt K, Szurman P (2012) The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute. Invest Ophthalmol Vis Sci 53(2):613–621. doi:10.1167/iovs.11-7322
Bayoudh W, Frentz M, Carstesen D, Dittrich B, Reismann C, Schrage NF, Walter P, Weinberger AW (2016) Intraocular silicone implant to treat chronic ocular hypotony-preliminary feasibility data. Graefes Arch Clin Exp Ophthalmol 254(11):2131–2139
Fischer S, Carstesen D, Klee D, Walter P, Weinberger AW (2012) Surface-modified silicone foils for intraocular implantation. Graefes Arch Clin Exp Ophthalmol 250(6):823–827. doi:10.1007/s00417-012-1956-1.
Bartzoka V, McDermott MR, Brook MA (1999) Protein-silicone interactions. Adv Mater 11(3):257–259
Groll J, Ameringer T, Spatz JP, Moeller M (2005) Ultrahin coatings form isocyanate- terminated star PEG prepolymers: layer formation and characterization. Langmuir 21(5):1991–1999
Heyes CD, Groll J, Möller M, Nienhaus GU (2007) Synthesis, patterning and applications of star-shaped poly(ethylene glycol) biofunctionalized surfaces. Mol BioSyst 3(6):419–430
Nagahama K, Saito T, Quchi T, Ohya Y (2011) Biodegradable nano-aggregates of star-shaped 8-arm PEG-PLLA block co-polymers for encapsulation of water-soluble macromolecules. J Biomater Sci Polym Ed 22(1–3):407–416
Satulovsky J, Caringano MA, Szleifer I (2000) Kinetic and thermodynamic control of protein adsorption. Proc Natl Acad Sci 97:9037–9041
Wakefield D, Cuello C, Di Girolamo N, Lloyd A (1999) The role of cytokines and chemokines in uveitis. Dev Ophthalmol 31:53–66
Magone MT, Whitcup SM (1999) Mechanisms of intraocular inflammation. Chem Immunol 73:90–119
Keller GK, Dahlke C, Kuckelkorn R, Schrage N (2003) Experience with the artificial iris diaphragm in hypotonic eyes. Ophthalmologe 100(3):203–208
Miller JB, Papakostas TD, Vavvas DG (2014) Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol 29(5–6):312–318
Furmanski J, Anderson M, Bal S, Greenwald AS, Halley D, Penenberg B, Ries M, Pruitt L (2009) Clinical fracture of cross-linked UHMWPE acetabular liners. Biomaterials 30(29):5572–5582. doi:10.1016/j.biomaterials.2009.07.013
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The Interdisciplinary Centre for Clinical Research “BIOMAT” and the START program, both within the faculty of Medicine at the RWTH Aachen University, provided financial support in the form of grant funding. The sponsor had no role in the design or conduct of this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, participation in speakers’ bureaus, membership, employment, consultancies, stock ownership, other equity interest, expert testimony, or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
Rights and permissions
About this article
Cite this article
Bayoudh, W., Carstesen, D., Walter, P. et al. Intraocular silicone implant to treat chronic ocular hypotony: an in vivo trial. Graefes Arch Clin Exp Ophthalmol 255, 1947–1955 (2017). https://doi.org/10.1007/s00417-017-3714-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-017-3714-x